Overexpression of GLI1 and GLI2 has been considered a prognostic parameter for DFS and OS in HPV-negative HNSCC patients undergoing surgical resection and postoperative radiotherapy [69]. The gene discussed is GLI2; the disease is head and neck squamous cell carcinoma.